Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
Fernández-Bergés, D.; Degano, I. R.; Gonzalez Fernandez, R.; Subirana, I.; Vila, J.; Jiménez-Navarro, M.; Perez-Fernandez, S.; Roqué, M.; Bayes-Genis, A.; Fernandez-Aviles, F.; Mayorga, A.; Bertomeu-Gonzalez, V.; Sanchis, J.; Rodríguez Esteban, M.; Sanchez-Hidalgo, A.; Sanchez-Insa, E.; Elorriaga, A.; Abuassi ., Emad; Nuñez, A.; Garcia Ruiz, J. M.; Morrondo Valdeolmillos, P.; Bosch-Portell, D.; Lekuona, I.; Carrillo-Lopez, A.; Zamora, A.; Vega-Hernandez, B.; Alameda Serrano, J.; Rubert, C.; Ruiz-Valdepeñas, L.; Quintas, L.; Rodríguez-Padial, L.; Vaquero, J.; Martinez Dolz, L.; Barrabes, J. A.; Sanchez, P. L.; Sionis, A.; Martí-Almor, J.; Elosua, R.; Lidon, R. M.; Garcia-Dorado, D.; Marrugat, J.
Date issued
2020Journal title
Open Heart
Type of content
Journal Article
DeCS
resultado del tratamiento | choque | anciano | edema pulmonar | factores de riesgo | recurrencia | evaluación de riesgos | humanos | factores de tiempo | sistema de registrosMeSH
Risk Factors | Risk Assessment | Pulmonary Edema | Humans | Treatment Outcome | Registries | Time Factors | Shock | Recurrence | AgedAbstract
OBJECTIVE: Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI >/=75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. The objective of this analysis was to determine the effectiveness of P-PCI in patients with STEMI >/=75 years. METHODS: We included 979 patients with STEMI >/=75 years, from the ATencion HOspitalaria del Sindrome coronario study, a registry of 8142 consecutive patients with acute coronary syndrome admitted at 31 Spanish hospitals in 2014-2016. We calculated a propensity score (PS) for the indication of P-PCI. Patients that received or not P-PCI were matched by PS. Using logistic regression, we compared the effectiveness of performing P-PCI versus non-performance for the composite primary event, which included death, reinfarction, acute pulmonary oedema or cardiogenic shock during hospitalisation. RESULTS: Of the included patients, 81.5 % received P-PCI. The matching provided two groups of 169 patients with and without P-PCI. Compared with its non-performance, P-PCI presented a composite event OR adjusted by PS of 0.55 (95% CI 0.34 to 0.89). CONCLUSIONS: Receiving a P-PCI was significantly associated with a reduced risk of major intrahospital complications in patients with STEMI aged 75 years or older.